Stem Cell Manufacturing Market Research Report - Forecast to 2027

Stem Cell Manufacturing Market: Information by Application (Therapy & Research & Cell), Product (Stem Cell Lines and Instruments, Consumables & Culture Media), End User (Pharmaceutical/Biotechnology Companies & CRO), & Region - Forecast till 2027

ID: MRFR/LS/5477-CR | April, 2019 | Region : Global

Table of Contents:

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

4.1 Drivers

4.2 Restraints

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Product Trends & Assessment

Chapter 5. Market Factor Analysis

5.1 Porter’s Five Forces Analysis

5.1.1 Bargaining Power of Suppliers

5.1.2 Bargaining Power of Buyers

5.1.3 Threat of New Entrants

5.1.4 Threat of Substitutes

5.1.5 Intensity of Rivalry

5.2 Value Chain Analysis

5.3 Investment Feasibility Analysis

5.4 Pricing Analysis

Chapter 6. Global Stem Cell Manufacturing Market, by Product

6.1 Introduction

6.2 Stem Cell Lines

6.2.1 Hematopoietic Stem Cells (HSCs)

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

6.2.2 Mesenchymal Stem Cells (MSCs)

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

6.2.3 Induced Pluripotent Stem Cell (iPSC)

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

6.2.4 Embryonic Stem Cell (ESC)

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

6.2.5 Others

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

6.3 Instruments

6.3.1 Bioreactors

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

6.3.2 Incubators

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

6.3.3 Cell Sorters

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

6.3.4 Others

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

6.4 Culture Media

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

6.5 Consumables

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

Chapter 7. Global Stem Cell Manufacturing Market, by Application

7.1 Introduction

7.2 Research

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

7.3 Target Identification

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

7.4 Therapy

7.4.1 Autologous

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

7.4.2 Allogeneic

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

7.5 Cell and Tissue Banking

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

Chapter 8. Global Stem Cell Manufacturing Market, by End User

8.1 Introduction

8.2 Hospitals

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

8.3 Pharmaceutical and Biotechnology Companies

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

8.4 Stem Cell Banks

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

8.5 Others

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

Chapter 9. Global Stem Cell Manufacturing Market, by Region

9.1 Introduction

9.2 Americas

9.2.1 North America

9.2.1.1 US

9.2.1.2 Canada

9.2.2 South America

9.3 Europe

9.3.1 Western Europe

9.3.1.1 Germany

9.3.1.2 France

9.3.1.3 Italy

9.3.1.4 Spain

9.3.1.5 UK

9.3.1.6 Rest of Western Europe

9.3.2 Eastern Europe

9.4 Asia-Pacific

9.4.1 Japan

9.4.2 China

9.4.3 India

9.4.4 Australia

9.4.5 South Korea

9.4.6 Rest of Asia-Pacific

9.5 Middle East & Africa

9.5.1 Middle East

9.5.2 Africa

Chapter 10. Company Landscape

10.1 Introduction

10.2 Market Share Analysis

10.3 Key Development & Strategies

Chapter 11. Company Profiles

11.1 LONZA

11.1.1 Company Overview

11.1.2 Product Overview

11.1.3 Financials Overview

11.1.4 Key Developments

11.1.5 SWOT Analysis

11.2 Bio-Rad Laboratories, Inc.

11.2.1 Company Overview

11.2.2 Product Overview

11.2.3 Financial Overview

11.2.4 Key Developments

11.2.5 SWOT Analysis

11.3 FUJIFILM CELLULAR DYNAMICS, INC. (FCDI)

11.3.1 Company Overview

11.3.2 Product Overview

11.3.3 Financial Overview

11.3.4 Key Development

11.3.5 SWOT Analysis

11.4 BD

11.4.1 Company Overview

11.4.2 Product Overview

11.4.3 Financial Overview

11.4.4 Key Development

11.4.5 SWOT Analysis

11.5 Thermo Fisher Scientific Inc.

11.5.1 Company Overview

11.5.2 Product Overview

11.5.3 Financial overview

11.5.4 Key Developments

11.5.5 SWOT Analysis

11.6 AbbVie Inc.

11.6.1 Company Overview

11.6.2 Product Overview

11.6.3 Financial Overview

11.6.4 Key Developments

11.6.5 SWOT Analysis

11.7 Bristol-Myers Squibb Company

11.7.1 Overview

11.7.2 Product Overview

11.7.3 Financial Overview

11.7.4 Key Developments

11.7.5 SWOT Analysis

11.8 GlaxoSmithKline plc.

11.8.1 Overview

11.8.2 Product Overview

11.8.3 Financials

11.8.4 Key Developments

11.8.5 SWOT Analysis

11.9 Teva Pharmaceutical Industries Ltd.

11.9.1 Overview

11.9.2 Product Overview

11.9.3 Financials

11.9.4 Key Developments

11.9.5 SWOT Analysis

11.10 Takeda Pharmaceutical Company Limited

11.10.1 Overview

11.10.2 Product Overview

11.10.3 Financials

11.10.4 Key Developments

11.10.5 SWOT Analysis

11.11 Merck KGaA

11.11.1 Overview

11.11.2 Product Overview

11.11.3 Financial Overview

11.11.4 Key Developments

11.11.5 SWOT Analysis

11.12 American CryoStem Corporation

11.12.1 Overview

11.12.2 Product Overview

11.12.3 Financials

11.12.4 Key Developments

11.12.5 SWOT Analysis

11.13 TAKARA BIO INC.

11.13.1 Overview

11.13.2 Product Overview

11.13.3 Financials

11.13.4 Key Developments

11.13.5 SWOT Analysis

11.14 Miltenyi Biotec

11.14.1 Overview

11.14.2 Product Overview

11.14.3 Financials

11.14.4 Key Developments

11.14.5 SWOT Analysis

11.15 STEMCELL Technologies Inc.

11.15.1 Overview

11.15.2 Product Overview

11.15.3 Financials

11.15.4 Key Developments

11.15.5 SWOT Analysis

Chapter 12 MRFR Conclusion

12.1 Key Findings

12.1.1 From CEO’s View point

12.1.2 Unmet Needs of the Market

12.2 Key Companies to Watch

12.3 Predictions for the Stem Cell Manufacturing Industry

Chapter 13. Appendix

LIST OF TABLES

Table 1 Global Stem Cell Manufacturing Market Synopsis, 2020–2027

Table 2 Global Stem Cell Manufacturing Market Estimates and Forecast, 2020–2027 (USD Million)

Table 3 Global Stem Cell Manufacturing Market, by Region, 2020–2027 (USD Million)

Table 4 Global Stem Cell Manufacturing Market, by Product, 2020–2027 (USD Million)

Table 5 Global Stem Cell Manufacturing Market, by Applications, 2020–2027 (USD Million)

Table 6 Global Stem Cell Manufacturing Market, by End User, 2020–2027 (USD Million)

Table 7 North America: Stem Cell Manufacturing Market, by Product, 2020–2027 (USD Million)

Table 8 North America: Stem Cell Manufacturing Market, by Applications, 2020–2027 (USD Million)

Table 9 North America: Stem Cell Manufacturing Market, by End User, 2020–2027 (USD Million)

Table 10 US: Stem Cell Manufacturing Market, by Product, 2020–2027 (USD Million)

Table 11 US: Stem Cell Manufacturing Market, by Applications, 2020–2027 (USD Million)

Table 12 US: Stem Cell Manufacturing Market, by End User, 2020–2027 (USD Million)

Table 13 Canada: Stem Cell Manufacturing Market, by Product, 2020–2027 (USD Million)

Table 14 Canada: Stem Cell Manufacturing Market, by Applications, 2020–2027 (USD Million)

Table 15 Canada: Stem Cell Manufacturing Market, by End User, 2020–2027 (USD Million)

Table 16 South America: Stem Cell Manufacturing Market, by Product, 2020–2027 (USD Million)

Table 17 South America: Stem Cell Manufacturing Market, by Applications, 2020–2027 (USD Million)

Table 18 South America: Stem Cell Manufacturing Market, by End User, 2020–2027 (USD Million)

Table 19 Europe: Stem Cell Manufacturing Market, by Product, 2020–2027 (USD Million)

Table 20 Europe: Stem Cell Manufacturing Market, by Applications, 2020–2027 (USD Million)

Table 21 Europe: Stem Cell Manufacturing Market, by End User, 2020–2027 (USD Million)

Table 22 Western Europe: Stem Cell Manufacturing Market, by Product, 2020–2027 (USD Million)

Table 23 Western Europe: Stem Cell Manufacturing Market, by Applications, 2020–2027 (USD Million)

Table 24 Western Europe: Stem Cell Manufacturing Market, by End User, 2020–2027 (USD Million)

Table 25 Eastern Europe: Stem Cell Manufacturing Market, by Product, 2020–2027 (USD Million)

Table 26 Eastern Europe: Stem Cell Manufacturing Market, by Applications, 2020–2027 (USD Million)

Table 27 Eastern Europe: Stem Cell Manufacturing Market, by End User, 2020–2027 (USD Million)

Table 28 Asia-Pacific: Stem Cell Manufacturing Market, by Product, 2020–2027 (USD Million)

Table 29 Asia-Pacific: Stem Cell Manufacturing Market, by Applications, 2020–2027 (USD Million)

Table 30 Asia-Pacific: Stem Cell Manufacturing Market, by End User, 2020–2027 (USD Million)

Table 31 Middle East & Africa: Stem Cell Manufacturing Market, by Product, 2020–2027 (USD Million)

Table 32 Middle East & Africa: Stem Cell Manufacturing Market, by Applications, 2020–2027 (USD Million)

Table 33 Middle East & Africa: Stem Cell Manufacturing Market, by End User, 2020–2027 (USD Million)

LIST OF FIGURES

Figure 1 Research Process

Figure 2 Market Structure for Global Stem Cell Manufacturing Market

Figure 3 Market Dynamics for Global Stem Cell Manufacturing Market

Figure 4 Global Stem Cell Manufacturing Market Share, by Product, 2020

Figure 5 Global Stem Cell Manufacturing Market Share, by Applications, 2020

Figure 6 Global Stem Cell Manufacturing Market Share, by End User, 2020

Figure 7 Global Stem Cell Manufacturing Market Share, by Region, 2020

Figure 8 North America: Stem Cell Manufacturing Market Share, by Country, 2020

Figure 9 Europe: Stem Cell Manufacturing Market Share, by Country, 2020

Figure 10 Asia-Pacific: Stem Cell Manufacturing Market Share, by Country, 2020

Figure 11 Middle East & Africa: Stem Cell Manufacturing Market Share, by Country, 2020

Figure 12 Global Stem Cell Manufacturing Market: Company Share Analysis, 2020 (%)

Figure 13 LONZA: Key Financials

Figure 14 LONZA: Segmental Revenue

Figure 15 LONZA: Geographical Revenue

Figure 16 Bio-Rad Laboratories, Inc.: Key Financials

Figure 17 Bio-Rad Laboratories, Inc.: Segmental Revenue

Figure 18 Bio-Rad Laboratories, Inc.: Geographical Revenue

Figure 19 FUJIFILM CELLULAR DYNAMICS, INC. (FCDI): Key Financials

Figure 20 FUJIFILM CELLULAR DYNAMICS, INC. (FCDI): Segmental Revenue

Figure 21 FUJIFILM CELLULAR DYNAMICS, INC. (FCDI): Geographical Revenue

Figure 22 BD: Key Financials

Figure 23 BD: Segmental Revenue

Figure 24 BD: Geographical Revenue

Figure 25 Thermo Fisher Scientific Inc.: Key Financials

Figure 26 Thermo Fisher Scientific Inc.: Segmental Revenue

Figure 27 Thermo Fisher Scientific Inc.: Geographical Revenue

Figure 28 AbbVie Inc.: Key Financials

Figure 29 AbbVie Inc.: Segmental Revenue

Figure 30 AbbVie Inc.: Geographical Revenue

Figure 31 Bristol-Myers Squibb Company: Key Financials

Figure 32 Bristol-Myers Squibb Company: Segmental Revenue

Figure 33 Bristol-Myers Squibb Company: Geographical Revenue

Figure 34 GlaxoSmithKline plc.: Key Financials

Figure 35 GlaxoSmithKline plc.: Segmental Revenue

Figure 36 GlaxoSmithKline plc.: Geographical Revenue

Figure 37 Teva Pharmaceutical Industries Ltd.: Key Financials

Figure 38 Teva Pharmaceutical Industries Ltd.: Segmental Revenue

Figure 39 Teva Pharmaceutical Industries Ltd.: Geographical Revenue

Figure 40 Takeda Pharmaceutical Company Limited: Key Financials

Figure 41 Takeda Pharmaceutical Company Limited: Segmental Revenue

Figure 42 Takeda Pharmaceutical Company Limited: Geographical Revenue

Figure 43 Merck KGaA: Key Financials

Figure 44 Merck KGaA: Segmental Revenue

Figure 45 Merck KGaA: Geographical Revenue

Figure 46 American CryoStem Corporation: Key Financials

Figure 47 American CryoStem Corporation: Segmental Revenue

Figure 48 American CryoStem Corporation: Geographical Revenue

Figure 49 TAKARA BIO INC.: Key Financials

Figure 50 TAKARA BIO INC.: Segmental Revenue

Figure 51 TAKARA BIO INC.: Geographical Revenue

Figure 52 Miltenyi Biotec: Key Financials

Figure 53 Miltenyi Biotec: Segmental Revenue

Figure 54 Miltenyi Biotec: Geographical Revenue

Figure 55 STEMCELL Technologies Inc.: Key Financials

Figure 56 STEMCELL Technologies Inc.: Segmental Revenue

Figure 57 STEMCELL Technologies Inc.: Geographical Revenue


Stem Cell Manufacturing Market